Aeglea BioTherapeutics

0 followers

‌

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Biotechnology

Headquarters

Austin, United States

Employees

51-200

Links

Org chart

Russell J. Cox

Chief Executive Officer, Epirium Bio

Russell J. Cox

Collapse

Cortney Caudill

Chief Product Officer

Eric Bradford

Chief Development Officer

Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Teams

Product Management Team

6 members

Clinical Development Team

3 members

Leadership Team

3 members

Similar companies

SpringWorks Therapeutics

5 followers

Genesis Therapeutics

1 follower

10X Genomics

13 followers

Charles River Laboratories

10 followers

Amyris

8 followers

Omeros

4 followers

Arrowhead Pharmaceuticals

4 followers

4D Molecular Therapeutics

3 followers

Cerus

2 followers

Quantum-Si

2 followers

ImmunityBio

2 followers

Explore companies